Arylamine N-Acetyltransferase 1 Activity is Regulated by the Protein Acetylation Status
Arylamine N-acetyltransferase 1 (NAT1) is a drug metabolizing enzyme that influences cancer cell proliferation and survival, especially in breast cancer. Lysine-acetylation is an important Post-Translational Modification (PTM) in the regulation of diverse cellular processes. Histone deacetylases (HD...
Guardado en:
Autores principales: | Raúl A. Salazar-González (Autor), Mark A. Doll (Autor), David W. Hein (Autor) |
---|---|
Formato: | Libro |
Publicado: |
Frontiers Media S.A.,
2022-01-01T00:00:00Z.
|
Materias: | |
Acceso en línea: | Connect to this object online. |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Arylamine N-acetyltransferase 2 genotype-dependent N-acetylation of isoniazid in cryopreserved human hepatocytes
por: Mark A. Doll, et al.
Publicado: (2017) -
Human N-Acetyltransferase 1 and 2 Differ in Affinity Towards Acetyl-Coenzyme A Cofactor and N-Hydroxy-Arylamine Carcinogens
por: David W. Hein, et al.
Publicado: (2022) -
Acetyl coenzyme A kinetic studies on N-acetylation of environmental carcinogens by human N-acetyltransferase 1 and its NAT1*14B variant
por: Mariam R. Habil, et al.
Publicado: (2022) -
A pilot study of the modulation of sirtuins on arylamine N-acetyltransferase 1 and 2 enzymatic activity
por: Eneida Turiján-Espinoza, et al.
Publicado: (2018) -
Arylamine N-acetyltransferase 2 gene polymorphism in an Algerian population
por: Hiba Chelouti, et al.
Publicado: (2017)